Sponsor Monitoring Practices, Inspection Readiness Criticized By FDA Reps
This article was originally published in The Gray Sheet
Executive Summary
FDA is considering changing its approach to foreign audits to address situations where agency inspectors felt they had insufficient time to complete inspections